RecruitingPulmonary HemorrhageCancer
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a drug study that will examine if inhaled tranexamic acid can improve mortality in patients with cancer-related pulmonary hemorrhage and respiratory failure as compared to usual care.
Sponsor: M.D. Anderson Cancer Center
You may qualify if…
- ✓ 1. Age \> 18 years old
- ✓ 2. Have a diagnosed hematological malignancy
- ✓ 3. Are actively receiving mechanical ventilation
- ✓ 4. Have evidence of pulmonary hemorrhage as defined by either
- ✓ 1. Persistently bloody secretions upon endotracheal tube suctioning, or
- ✓ 2. Evidence of diffuse alveolar hemorrhage by bronchoscopic examination
- ✓ 5. Signed informed consent by patient or if the subject lacks decision-making capacity, the subject's legally authorized representative
- ✓ 2.3.2 Exclusion Criteria
Where it's recruiting
Texas
Houston
Source: ClinicalTrials.gov · NCT05053867 · last updated 2026-01-14